Search
Displaying 341–350 of 894 results for “vision connection”
-
Optogenetic Therapy Takes First Step Forward in Clinical Trial
Research NewsRetroSense’s optogenetic therapy is designed to restore vision to people who are completely blind from retinal degenerative diseases such as retinitis pigmentosa by bestowing light sensitivity to retinal ganglion cells, which survive after photoreceptors, the cells that make vision possible, are lost.
-
Need-to-Know Information about Clinical Trials
Research NewsA primer on what you can expect from clinical trials.
-
Genetics 101: How Some Retinal Diseases are Inherited
Research NewsTo understand heredity, you have to know a little about genetics. Below is a review of the three major genetic-disease inheritance patterns.
-
Research News
Thanks to recent advances in stem cell research, we are getting closer to replacing cells in the retina lost to diseases such as retinitis pigmentosa and age-related macular degeneration.
-
The FDA's Indispensible Role (a guest blog from Dr. Patricia Zilliox)
Research NewsWhile it may not seem obvious, the FDA ultimately drives everything — the researchers and the money. That’s because without FDA approval, you have no treatment, even if you have great research and adequate funding.
-
The Importance of Stem Cells (a guest post from Dr. David Gamm)
Research NewsDr. David Gamm on the potential of stem cell research to benefit patients with retinal degenerations.
-
Research News
The study is designed to evaluate the pharmacodynamics, safety and tolerability of emixustat in subjects with macular atrophy secondary to Stargardt disease.
-
Stargardt Disease Research Advances
Research NewsRecent developments in research on Stargardt disease.
-
Whether you’re supporting someone with vision loss or looking to deepen your own understanding, these resources — developed in collaboration with the blind and low vision community — are designed to help therapists provide thoughtful, informed care.
